Transmedics Group Inc reports results for the quarter ended in March - Earnings Summary

TransMedics

01/05/2023 23:05

* Transmedics Group Inc  TMDX.OQ  reported a quarterly
adjusted
loss of 8 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 25 cents per share.
    * Revenue rose 161.7% to $41.55 million from a year ago;
analysts
expected $37.93 million. 
    * Transmedics Group Inc's reported EPS for the quarter was a
loss
of 8 cents​.
    * The mean earnings estimate of analysts had risen by
about 9.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Transmedics Group Inc shares had risen by 4.5% this
quarter and
gained 28.2% so far this year.
    * The company reported a quarterly loss of $2.64 million.
    * Wall Street's median 12-month price target for Transmedics
Group
Inc is $88.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
1 at 10:05 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.25          -0.08          Beat
 Dec. 31 2022      -0.30          -0.21          Beat
 Sep. 30 2022      -0.41          -0.25          Beat
 Jun. 30 2022      -0.35          -0.41          Missed